How much did Yourgene Health achieve in EBIT for the current year?
In the current year, Yourgene Health has achieved an EBIT of -5.66 M GBP.
Yourgene Health EBIT 2024
Yourgene Health EBIT
-5.66 M GBP
Ticker
YGEN.L
ISIN
GB00BN31ZD89
WKN
A116JH
In 2024, Yourgene Health's EBIT was -5.66 M GBP, a -37.08% increase from the -8.99 M GBP EBIT recorded in the previous year.
The Yourgene Health EBIT history
| YEAR | EBIT (undefined GBP) |
|---|---|
| 2027e | - |
| 2026e | - |
| 2025e | - |
| 2024e | - |
| 2023e | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
| 2014 | - |
| 2013 | - |
| 2012 | - |
| 2011 | - |
| 2010 | - |
| 2009 | - |
| 2008 | - |
| 2007 | - |
| 2006 | - |
| 2005 | - |
| 2004 | - |
| 2003 | - |
Yourgene Health Revenue, EBIT, Net Income GB00BN31ZD89 · A116JH
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Yourgene Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Yourgene Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Yourgene Health’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Yourgene Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Yourgene Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Yourgene Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Yourgene Health’s growth potential.
Yourgene Health Revenue, EBIT and net profit per share
| Date | Yourgene Health Revenue | Yourgene Health EBIT | Yourgene Health Net Income |
|---|---|---|---|
| 2027e | 34.62 M undefined | -3.39 M undefined | -9.96 M undefined |
| 2026e | 26.82 M undefined | -1.68 M undefined | 0 undefined |
| 2025e | 21.61 M undefined | -3.74 M undefined | -4.03 M undefined |
| 2024e | 19.49 M undefined | -5.66 M undefined | -5.06 M undefined |
| 2023e | 18.89 M undefined | -8.99 M undefined | -20.17 M undefined |
| 2022 | 37.56 M undefined | -1.5 M undefined | -1.92 M undefined |
| 2021 | 18.29 M undefined | -6.25 M undefined | -12.18 M undefined |
| 2020 | 16.61 M undefined | -2.44 M undefined | -2.43 M undefined |
| 2019 | 8.88 M undefined | -4.66 M undefined | 3.39 M undefined |
| 2018 | 6.15 M undefined | -5.9 M undefined | -9.48 M undefined |
| 2017 | 3.08 M undefined | -6.91 M undefined | -7.86 M undefined |
| 2016 | 2.45 M undefined | -6 M undefined | -12.08 M undefined |
| 2015 | 132,270 undefined | -4.68 M undefined | -7.45 M undefined |
| 2014 | 60,000 undefined | -1.66 M undefined | -4.93 M undefined |
| 2013 | 260,000 undefined | -4.96 M undefined | -4.66 M undefined |
| 2012 | 50,000 undefined | -5.39 M undefined | -4.9 M undefined |
| 2011 | 60,000 undefined | -6.36 M undefined | -5.83 M undefined |
| 2010 | 150,000 undefined | -6.16 M undefined | -5.67 M undefined |
| 2009 | 130,000 undefined | -6.22 M undefined | -5.76 M undefined |
| 2008 | 30,000 undefined | -5.38 M undefined | -4.87 M undefined |
| 2007 | 270,000 undefined | -1.58 M undefined | -1.83 M undefined |
| 2006 | 10,000 undefined | -260,000 undefined | -70,000 undefined |
| 2005 | 20,000 undefined | -250,000 undefined | 590,000 undefined |
| 2004 | 50,000 undefined | -330,000 undefined | -400,000 undefined |
| 2003 | 30,000 undefined | -480,000 undefined | -2.4 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2003 | 30,000 GBP | -480,000 GBP | -2.4 M GBP |
| 2004 | 50,000 GBP | -330,000 GBP | -400,000 GBP |
| 2005 | 20,000 GBP | -250,000 GBP | 590,000 GBP |
| 2006 | 10,000 GBP | -260,000 GBP | -70,000 GBP |
| 2007 | 270,000 GBP | -1.58 M GBP | -1.83 M GBP |
| 2008 | 30,000 GBP | -5.38 M GBP | -4.87 M GBP |
| 2009 | 130,000 GBP | -6.22 M GBP | -5.76 M GBP |
| 2010 | 150,000 GBP | -6.16 M GBP | -5.67 M GBP |
| 2011 | 60,000 GBP | -6.36 M GBP | -5.83 M GBP |
| 2012 | 50,000 GBP | -5.39 M GBP | -4.9 M GBP |
| 2013 | 260,000 GBP | -4.96 M GBP | -4.66 M GBP |
| 2014 | 60,000 GBP | -1.66 M GBP | -4.93 M GBP |
| 2015 | 132,270 GBP | -4.68 M GBP | -7.45 M GBP |
| 2016 | 2.45 M GBP | -6 M GBP | -12.08 M GBP |
| 2017 | 3.08 M GBP | -6.91 M GBP | -7.86 M GBP |
| 2018 | 6.15 M GBP | -5.9 M GBP | -9.48 M GBP |
| 2019 | 8.88 M GBP | -4.66 M GBP | 3.39 M GBP |
| 2020 | 16.61 M GBP | -2.44 M GBP | -2.43 M GBP |
| 2021 | 18.29 M GBP | -6.25 M GBP | -12.18 M GBP |
| 2022 | 37.56 M GBP | -1.5 M GBP | -1.92 M GBP |
| 2023e | 18.89 M GBP | -8.99 M GBP | -20.17 M GBP |
| 2024e | 19.49 M GBP | -5.66 M GBP | -5.06 M GBP |
| 2025e | 21.61 M GBP | -3.74 M GBP | -4.03 M GBP |
| 2026e | 26.82 M GBP | -1.68 M GBP | 0 GBP |
| 2027e | 34.62 M GBP | -3.39 M GBP | -9.96 M GBP |
Yourgene Health stock margins GB00BN31ZD89 · A116JH
The Yourgene Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Yourgene Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Yourgene Health.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Yourgene Health's sales revenue. A higher gross margin percentage indicates that the Yourgene Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Yourgene Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Yourgene Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Yourgene Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Yourgene Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Yourgene Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Yourgene Health Margin History
| Yourgene Health Gross margin | Yourgene Health Profit margin | Yourgene Health EBIT margin | Yourgene Health Profit margin |
|---|---|---|---|
| 2027e | 56.88 % | -9.8 % | -28.78 % |
| 2026e | 56.88 % | -6.25 % | 0 % |
| 2025e | 56.88 % | -17.29 % | -18.65 % |
| 2024e | 56.88 % | -29.02 % | -25.98 % |
| 2023e | 56.88 % | -47.59 % | -106.82 % |
| 2022 | 56.88 % | -3.98 % | -5.1 % |
| 2021 | 62.2 % | -34.15 % | -66.62 % |
| 2020 | 61.55 % | -14.69 % | -14.65 % |
| 2019 | 51.91 % | -52.51 % | 38.16 % |
| 2018 | 51.62 % | -95.97 % | -154.27 % |
| 2017 | 41.65 % | -224.57 % | -255.27 % |
| 2016 | 28.58 % | -244.52 % | -492.45 % |
| 2015 | 100 % | -3,539.44 % | -5,630.54 % |
| 2014 | -216.67 % | -2,766.67 % | -8,216.67 % |
| 2013 | -115.38 % | -1,907.69 % | -1,792.31 % |
| 2012 | -780 % | -10,780 % | -9,800 % |
| 2011 | -800 % | -10,600 % | -9,716.67 % |
| 2010 | -120 % | -4,106.67 % | -3,780 % |
| 2009 | 92.31 % | -4,784.62 % | -4,430.77 % |
| 2008 | 100 % | -17,933.33 % | -16,233.33 % |
| 2007 | 100 % | -585.19 % | -677.78 % |
| 2006 | 56.88 % | -2,600 % | -700 % |
| 2005 | 56.88 % | -1,250 % | 2,950 % |
| 2004 | 56.88 % | -660 % | -800 % |
| 2003 | 56.88 % | -1,600 % | -8,000 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2003 | 56.88 % | -1,600 % | -8,000 % |
| 2004 | 56.88 % | -660 % | -800 % |
| 2005 | 56.88 % | -1,250 % | 2,950 % |
| 2006 | 56.88 % | -2,600 % | -700 % |
| 2007 | 100 % | -585.19 % | -677.78 % |
| 2008 | 100 % | -17,933.33 % | -16,233.33 % |
| 2009 | 92.31 % | -4,784.62 % | -4,430.77 % |
| 2010 | -120 % | -4,106.67 % | -3,780 % |
| 2011 | -800 % | -10,600 % | -9,716.67 % |
| 2012 | -780 % | -10,780 % | -9,800 % |
| 2013 | -115.38 % | -1,907.69 % | -1,792.31 % |
| 2014 | -216.67 % | -2,766.67 % | -8,216.67 % |
| 2015 | 100 % | -3,539.44 % | -5,630.54 % |
| 2016 | 28.58 % | -244.52 % | -492.45 % |
| 2017 | 41.65 % | -224.57 % | -255.27 % |
| 2018 | 51.62 % | -95.97 % | -154.27 % |
| 2019 | 51.91 % | -52.51 % | 38.16 % |
| 2020 | 61.55 % | -14.69 % | -14.65 % |
| 2021 | 62.2 % | -34.15 % | -66.62 % |
| 2022 | 56.88 % | -3.98 % | -5.1 % |
| 2023e | 56.88 % | -47.59 % | -106.82 % |
| 2024e | 56.88 % | -29.02 % | -25.98 % |
| 2025e | 56.88 % | -17.29 % | -18.65 % |
| 2026e | 56.88 % | -6.25 % | 0 % |
| 2027e | 56.88 % | -9.8 % | -28.78 % |
Yourgene Health Aktienanalyse
What does Yourgene Health do?
Yourgene Health PLC is an international life science company specializing in the development and marketing of DNA tests for various areas of health. The company, based in Manchester, England, was founded in 2009 and has been listed on the London Stock Exchange since 2013. The business model of Yourgene Health is to offer genetic tests for a variety of applications in order to improve people's well-being, health, and quality of life. The company has extensive experience in developing DNA diagnostic tests and offers a wide range of solutions for different markets. One of the core divisions of the company is oncology. Here, Yourgene Health PLC develops innovative test methods to identify and combat cancer cells and their growth. Another important area is reproductive health, where the company offers prenatal testing as well as fertility analysis. In Yourgene Health's broad product range, there are prenatal tests for the examination of chromosomal abnormalities in the fetus, tests for the analysis of genetic risks for hereditary diseases or thyroid diseases. The company also offers tests for the detection of bacteria and viruses, which serve as companion tests for infections. One of Yourgene Health's newest products is the Covid-19 PCR test. This test is performed through nasal and throat swabs and can provide an accurate diagnosis of coronavirus infection within a few hours. The test was developed in 2020 and has since proven to be an important measure in containing the pandemic along the test-trace-isolate model. In recent years, Yourgene Health has made numerous collaborations and acquisitions to strengthen its market position in different countries. This includes the acquisition of the US company Elucigene Diagnostics, a provider of DNA test solutions for reproductive health, in 2021. As part of its growth strategy, the company has announced expansion plans for Asia, particularly for China and Japan. For this purpose, the subsidiary Yourgene Health Shanghai was established in 2019. Yourgene Health PLC is an innovative company operating in a rapidly growing market. Through continuous development of new innovative test methods, implementation of collaborations and acquisitions, and expansion into new markets, the company is well positioned to achieve further growth successes and improve global health for consumers. Yourgene Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Yourgene Health's EBIT
Yourgene Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Yourgene Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Yourgene Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Yourgene Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Yourgene Health stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Yourgene Health.
How has the EBIT of Yourgene Health developed in recent years?
The EBIT of Yourgene Health has increased by -37.079% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Yourgene Health?
The EBIT of Yourgene Health is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Yourgene Health pay?
Over the past 12 months, Yourgene Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Yourgene Health is expected to pay a dividend of 0 GBP.
What is the dividend yield of Yourgene Health?
The current dividend yield of Yourgene Health is .
When does Yourgene Health pay dividends?
Yourgene Health pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Yourgene Health?
Yourgene Health paid dividends every year for the past 0 years.
What is the dividend of Yourgene Health?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Yourgene Health located?
Yourgene Health is assigned to the 'Health' sector.
Wann musste ich die Aktien von Yourgene Health kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Yourgene Health from 10/2/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Yourgene Health pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Yourgene Health in the year 2023?
In the year 2023, Yourgene Health distributed 0 GBP as dividends.
In which currency does Yourgene Health pay out the dividend?
The dividends of Yourgene Health are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Yourgene Health stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Yourgene Health
Our stock analysis for Yourgene Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yourgene Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Yourgene Health Revenue
- Yourgene Health Net Income
- Yourgene Health P/E
- Yourgene Health P/S
- Yourgene Health EBIT
- Yourgene Health Dividend
- Yourgene Health Stocks
- Yourgene Health Market capitalization
- Yourgene Health Debt
- Yourgene Health Liabilities
- Yourgene Health Equity
- Yourgene Health AAQS
- Yourgene Health Employees
- Yourgene Health ROE
- Yourgene Health ROA
- Yourgene Health ROCE
